Gene · 81607
Papers1,879
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,879
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Trimbody with rigid AI-designed scaffolds enables atomic-resolution cryo-EM structure determination of small proteins. | Nat Commun | 2026 | 41735342 | PubTator, text mining | PubMed |
| Dulaglutide Effect on Proteins Associated With CKD Progression. | Kidney Int Rep | 2026 | 41732754 | PubTator, text mining | PubMed |
| Reprogramming the immune microenvironment in triple-negative breast cancer with mRNA therapeutics. | Cancer Lett | 2026 | 41730382 | PubTator, text mining | PubMed |
| The role of antibody-drug conjugates in the treatment of lung cancer. | Front Oncol | 2026 | 41727667 | PubTator, text mining | PubMed |
| Deep learning-based non-invasive profiling of tumor transcriptomes from cell-free DNA for precision oncology. | bioRxiv | 2026 | 41726945 | PubTator, text mining | PubMed |
| A Case of Upper Tract Urothelial Carcinoma With Neuroendocrine Differentiation Successfully Treated With Enfortumab Vedotin and Pembrolizumab. | IJU Case Rep | 2026 | 41726849 | PubTator, text mining | PubMed |
| Illustrating a multidimensional roadmap using biomarkers and therapeutics to reshape outcomes in gastroesophageal cancer. | Ther Adv Med Oncol | 2026 | 41709926 | PubTator, text mining | PubMed |
| Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer. | N Engl J Med | 2026 | 41707170 | PubTator, text mining | PubMed |
| Toripalimab in patients with previously treated advanced upper tract urothelial carcinoma: a subgroup analysis of the phase II POLARIS-03 trial. | Oncologist | 2026 | 41701175 | PubTator, text mining | PubMed |
| Natural killer and CAR-NK cell therapies in urological cancers: Progress, mechanistic lessons from CAR-T, and future directions. | Crit Rev Oncol Hematol | 2026 | 41692037 | PubTator, text mining | PubMed |
| TROP2 expression is associated with early stage and favorable prognosis in upper tract urothelial carcinoma. | World J Urol | 2026 | 41686301 | PubTator, text mining | PubMed |
| Dual Immunological Prognostic Models for Risk Stratification and Treatment Insights in Triple-Negative Breast Cancer. | Int J Mol Sci | 2026 | 41683914 | PubTator, text mining | PubMed |
| Current Landscape and Evolving Role of Targeted Agents in Urothelial Carcinoma. | Cancers (Basel) | 2026 | 41681881 | PubTator, text mining | PubMed |
| Expression of Nectin-4 and Trop-2 in upper tract urothelial carcinoma: implications for biomarker-driven antibody-drug conjugate therapy. | J Pathol Clin Res | 2026 | 41680099 | PubTator, text mining | PubMed |
| T Cell Exhaustion in Hepatocellular Carcinoma: A Substantial Barrier in Immunotherapy. | J Cell Mol Med | 2026 | 41645702 | PubTator, text mining | PubMed |
| Oncolytic viruses: advanced strategies in cancer therapy. | Signal Transduct Target Ther | 2026 | 41639062 | PubTator, text mining | PubMed |
| Bismuth Bicycles. | J Pept Sci | 2026 | 41634948 | PubTator, text mining | PubMed |
| Micropapillary Urothelial Carcinoma: A Review and Update. | Adv Anat Pathol | 2026 | 41609241 | PubTator, text mining | PubMed |
| [From nontargeted to precision oncology: predictive biomarkers and targeted therapies in advanced urothelial carcinoma]. | Urologie | 2026 | 41603912 | PubTator, text mining | PubMed |
| Machine Learning in Biomarker-Driven Precision Oncology: Automated Immunohistochemistry Scoring and Emerging Directions in Genitourinary Cancers. | Curr Oncol | 2026 | 41590351 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/81607/papers?page=8